What is the END Fund? The END Fund is the world's first private philanthropic initiative to combat the five most common neglected tropical diseases (NTDs) that, together, cause up to 90% of the NTD burden in sub-Saharan Africa. Supported by a group of global philanthropists, the END Fund provides financing for nationwide disease control initiatives, creating new programs, supplementing existing ones, and using leveraged funds to extend and deepen the impact. The END Fund provides exceptional return on investment by harnessing the highly scalable impact of low-cost mass drug administrations. Learn more The Best Buy in Public Health NTDs bring misery to hundreds of millions of people each year, but just 50 cents funds a rapid-impact package of medication to treat an individual for the five most common NTDs. The Best Buy in Education Studies show that NTD treatment is the single most cost-effective means of improving children’s attendance and increasing capacity to learn and concentrate in school.